INOVIO PHARMACEUTICALS, INC. Annual Interest Expense in USD from 2017 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Inovio Pharmaceuticals, Inc. quarterly/annual Interest Expense history and growth rate from 2017 to 2023.
  • Inovio Pharmaceuticals, Inc. Interest Expense for the quarter ending March 31, 2024 was $178K, a 43.3% decline year-over-year.
  • Inovio Pharmaceuticals, Inc. Interest Expense for the twelve months ending March 31, 2024 was $1.09M, a 13.3% decline year-over-year.
  • Inovio Pharmaceuticals, Inc. annual Interest Expense for 2023 was $1.22M, a 2.49% decline from 2022.
  • Inovio Pharmaceuticals, Inc. annual Interest Expense for 2022 was $1.25M, a 35.2% decline from 2021.
  • Inovio Pharmaceuticals, Inc. annual Interest Expense for 2021 was $1.94M, a 77.7% decline from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $1.22M -$31.2K -2.49% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-06
2022 $1.25M -$682K -35.2% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-06
2021 $1.94M -$6.77M -77.7% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-06
2020 $8.7M +$754K +9.49% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-01
2019 $7.95M +$7.95M Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
2018 $0 -$25.9K -100% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-01
2017 $25.9K Jan 1, 2017 Dec 31, 2017 10-K 2020-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.